Mark T. Preissler, Ph.D.

2004 Albany Medical College of Union University 
"Mark Preissler"


Sign in to add mentor
Edmund J. Gosselin grad student 2004 Albany Medical College of Union University
 (Utilization of receptors for IgG for the inhibition and elimination of antigen-specific B lymphocytes.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Adamova E, Walsh MC, Gosselin DR, et al. (2005) Enhanced antigen-specific antibody and cytokine responses when targeting antigen to human FcGAMMA receptor type I using an anti-human FcGAMMA receptor type I-streptavidin fusion protein in an adjuvant-free system. Immunological Investigations. 34: 417-29
Preissler MT, Kaiser L, Drake JR, et al. (2005) Low-level signaling generated by FcgammaRIIB-B cell receptor co-ligation establishes a state of global B cell receptor nonresponsiveness. Immunological Investigations. 34: 53-70
Preissler MT, Walsh MC, Banas JA, et al. (2003) Generation of a human IgG3-streptavidin fusion protein. Implications for the inhibition and elimination of auto-reactive B cells. Human Antibodies. 12: 77-92
Jordan RA, Preissler MT, Banas JA, et al. (2003) Production of genetically engineered biotinylated interleukin-2 and its application in a rapid nonradioactive assay for T-cell activation. Clinical and Diagnostic Laboratory Immunology. 10: 339-44
Walsh MC, Banas JA, Mudzinski SP, et al. (2003) A two-component modular approach for enhancing T-cell activation utilizing a unique anti-FcgammaRI-streptavidin construct and microspheres coated with biotinylated-antigen. Biomolecular Engineering. 20: 21-33
Plitnick LM, Jordan RA, Banas JA, et al. (2001) Lipoteichoic acid inhibits interleukin-2 (IL-2) function by direct binding to IL-2. Clinical and Diagnostic Laboratory Immunology. 8: 972-9
See more...